Plain-English translation of NCT07531056 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Keloids are thick, raised scars that can grow beyond the original injury and cause pain, itching, or appearance concerns. This trial is testing whether combining two treatments—freezing the scar with liquid nitrogen followed by injections of 5-fluorouracil (a medication that helps shrink scar tissue)—works better than the medication injections alone.
Keloids can be difficult to treat, and doctors are looking for affordable, effective combinations of treatments that work well together. This trial will help determine if adding the freezing step makes the medication injections more successful.
You likely qualify if…
You likely don't qualify if…
If you join, you will be randomly assigned to one of two treatment groups. One group will receive freezing treatment followed 30 minutes later by medication injections into the keloid; the other group will receive the medication injections alone. Both treatments are done in the hospital clinic. You will have photos taken and your scar assessed at the start and during follow-up visits so doctors can track how well the treatment works.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Pakistan